The era of AstraZeneca’s distribution of cost-priced vaccines is over. At the time of the announcement of its preparation, developed with the University of Oxford, the Anglo-Swedish multinational had assured its intention to distribute vials all over the world without profit until the persistence of the pandemic. Now the pharmaceutical company believes that the global health emergency has become endemic, that is to say like a flu, and for this reason it communicates a reversal of the trend on profits.
AstraZeneca aims for profits on vaccines: the reasons for the change
“Covid is no longer a pandemic because the virus is becoming endemic” is how AstraZeneca motivated the change of strategy with a note, deciding to no longer make agreements to supply vials at low cost (we had talked about it who).
According to data updated at the end of September AstraZeneca has distributed 1.5 billion doses of its vaccine globally a a price between 4 and 8 dollars per dose, the lowest of all Covid-19 vaccines and far below Pfizer’s $ 19 or Moderna’s $ 30 (who the hypothesis of a stop for the under 30s in Germany and France on this vaccine).
Releasing its earnings for the third quarter of the year, the Anglo-Swedish pharmaceutical company announced that it plans for the near future a “modest profitability” thanks to new orders for the Vaxzevria vaccine.
AstraZeneca aims for profits on vaccines: announcement
“We started without profit to help overcome the global health crisis, but we always said we would move on to making a profit on the vaccine. It’s not something we think we’re making a huge profit on but the virus is becoming endemic, which means we have to learn to live with it ”explained CEO Pascal Soriot (who all the latest on the third dose).
However, the company’s CEO has no regrets about missing out on the opportunity to make a profit from selling the vaccine right from the start.
“I absolutely do not regret it. We are proud as a company of the impact we have had: we have saved millions of people from hospitalization and death. The AstraZeneca team continues to do a spectacular job, ”Soriot added, ensuring that the prices of your product will vary from country to country to continue to ensure access to the vaccine as much as possible for all (who we talked about the new drug from the pharmaceutical company).
– .
